The role of complement in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic liver diseases globally. NAFLD includes a range of hepatic manifestations, starting with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis, cirrhosis or even hepatocellular carcinoma. Although...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Zhenya Guo, Xiude Fan, Jianni Yao, Stephen Tomlinson, Guandou Yuan, Songqing He
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2022-09-01
סדרה:	Frontiers in Immunology
נושאים:	complement system nonalcoholic fatty liver disease site-targeted inhibitor inflammation liver
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017467/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!